196 related articles for article (PubMed ID: 7914406)
1. Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100).
Sognier MA; Zhang Y; Eberle RL; Sweet KM; Altenberg GA; Belli JA
Biochem Pharmacol; 1994 Jul; 48(2):391-401. PubMed ID: 7914406
[TBL] [Abstract][Full Text] [Related]
2. Characterization of adriamycin-resistant and radiation-sensitive Chinese hamster cell lines.
Sognier MA; Zhang Y; Eberle RL; Belli JA
Biochem Pharmacol; 1992 Nov; 44(9):1859-68. PubMed ID: 1360213
[TBL] [Abstract][Full Text] [Related]
3. Interaction between radiation and drug damage in mammalian cells. VI. Radiation and doxorubicin age-response function of doxorubicin-sensitive and -resistant Chinese hamster cells.
Zhang Y; Sweet KM; Sognier MA; Belli JA
Radiat Res; 1992 Oct; 132(1):105-11. PubMed ID: 1410265
[TBL] [Abstract][Full Text] [Related]
4. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes.
Thierry AR; Vigé D; Coughlin SS; Belli JA; Dritschilo A; Rahman A
FASEB J; 1993 Apr; 7(6):572-9. PubMed ID: 8097173
[TBL] [Abstract][Full Text] [Related]
5. An enhanced ability for transforming adriamycin into a noncytotoxic form in a multidrug-resistant cell line (LZ-8).
Zhang Y; Sweet KM; Sognier MA; Belli JA
Biochem Pharmacol; 1992 Nov; 44(9):1869-77. PubMed ID: 1360214
[TBL] [Abstract][Full Text] [Related]
6. High cell density-dependent resistance and P-glycoprotein-mediated multidrug resistance in mitoxantrone-selected Chinese hamster cells.
Muller C; Laval F; Soues S; Birck C; Charcosset JY
Biochem Pharmacol; 1992 May; 43(10):2091-102. PubMed ID: 1376119
[TBL] [Abstract][Full Text] [Related]
7. Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin.
Thierry AR; Jorgensen TJ; Forst D; Belli JA; Dritschilo A; Rahman A
Cancer Commun; 1989; 1(5):311-6. PubMed ID: 2577154
[TBL] [Abstract][Full Text] [Related]
8. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
Toffoli G; Simone F; Gigante M; Boiocchi M
Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
Cuvier C; Roblot-Treupel L; Millot JM; Lizard G; Chevillard S; Manfait M; Couvreur P; Poupon MF
Biochem Pharmacol; 1992 Aug; 44(3):509-17. PubMed ID: 1354963
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
Nygren P; Larsson R; Gruber A; Peterson C; Bergh J
Br J Cancer; 1991 Dec; 64(6):1011-8. PubMed ID: 1684906
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
13. Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells.
Weaver JL; Pine PS; Aszalos A; Schoenlein PV; Currier SJ; Padmanabhan R; Gottesman MM
Exp Cell Res; 1991 Oct; 196(2):323-9. PubMed ID: 1680064
[TBL] [Abstract][Full Text] [Related]
14. Functional intracellular P-glycoprotein.
Shapiro AB; Fox K; Lee P; Yang YD; Ling V
Int J Cancer; 1998 Jun; 76(6):857-64. PubMed ID: 9626353
[TBL] [Abstract][Full Text] [Related]
15. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.
Harker WG; Sikic BI
Cancer Res; 1985 Sep; 45(9):4091-6. PubMed ID: 4028002
[TBL] [Abstract][Full Text] [Related]
16. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
Coley HM; Amos WB; Twentyman PR; Workman P
Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
[TBL] [Abstract][Full Text] [Related]
17. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.
Taylor CW; Dalton WS; Parrish PR; Gleason MC; Bellamy WT; Thompson FH; Roe DJ; Trent JM
Br J Cancer; 1991 Jun; 63(6):923-9. PubMed ID: 1676902
[TBL] [Abstract][Full Text] [Related]
18. Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells.
Tomida A; Tatsuta T; Suzuki H
Jpn J Cancer Res; 1991 Jan; 82(1):127-33. PubMed ID: 1671855
[TBL] [Abstract][Full Text] [Related]
19. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein.
Kartner N; Shales M; Riordan JR; Ling V
Cancer Res; 1983 Sep; 43(9):4413-9. PubMed ID: 6135505
[TBL] [Abstract][Full Text] [Related]
20. Bile acid inhibition of P-glycoprotein-mediated transport in multidrug-resistant cells and rat liver canalicular membrane vesicles.
Mazzanti R; Fantappié O; Kamimoto Y; Gatmaitan Z; Gentilini P; Arias IM
Hepatology; 1994 Jul; 20(1 Pt 1):170-6. PubMed ID: 7912687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
